Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
Authors:
- Akinobu TaketomiATAkinobu Taketomi
- Kensaku SanefujiKSKensaku Sanefuji
- Yuji SoejimaYSYuji Soejima
- Tomoharu YoshizumiTYTomoharu Yoshizumi
- Hideaki UhciyamaHUHideaki Uhciyama
- Toru IkegamiTIToru Ikegami
- Noboru HaradaNHNoboru Harada
- Yoichi YamashitaYYYoichi Yamashita
- Keishi SugimachiKSKeishi Sugimachi
- Hiroto KayashimaHKHiroto Kayashima
- Tomohiro IguchiTITomohiro Iguchi
- Yoshihko MaeharaYMYoshihko Maehara
- 27 February 2009
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 87 (4) , 531-537
Abstract
Because many patients who did not meet the Milan criteria have survived long after undergoing living donor liver transplantation (LDLT), extended criteria for recipient with hepatocellular carcinoma (HCC) are therefore considered to be necessary. A total of 90 consecutive adult LDLT recipients with HCC between 1996 and 2007 were reviewed. The recurrence-free survival rates of all 90 patients were 86.0%, 81.3%, and 81.3% at 1, 3, and 5 years, respectively. Fourteen of 90 patients developed a recurrence of tumor after the LDLT. The tumor recurrences were diagnosed within 1 year after the LDLT in 11 (78.6%) patients. In a multivariate analysis, both the tumor size of less than 5 cm (P=0.0202) and the des-gamma-carboxy prothrombin (DCP) level of less than 300 mAU/mL (P=0.0001) were found to be favorable independent factors for the recurrence of HCC after LDLT. Therefore, the authors devised new selection criteria for HCC patients (a tumor size of <5 cm or a DCP of <300 mAU/mL). The 1-, 3-, and 5-year overall or recurrence-free survival rates of the 85 patients who met the new criteria were 92.3%, 85.9%, and 82.7%, or 90.5%, 87.0%, and 87.0%, respectively, which were significantly different from those of the five patients who did not meet the new criteria (P<0.0001). A combination of two factors, namely the tumor size and the DCP level, was found to be useful for expanding the selection of LDLT candidates for HCC.Keywords
This publication has 29 references indexed in Scilit:
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policyGastroenterology, 2004
- The role and limitation of living donor liver transplantation for hepatocellular carcinomaLiver Transplantation, 2004
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996
- Successful living-related partial liver transplantation to an adult patientThe Lancet, 1994
- Hepatic Resection Versus Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 1991
- Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patientsWorld Journal of Surgery, 1991
- Successful Liver Transplantation from a Living Donor to Her SonNew England Journal of Medicine, 1990
- LIVER TRANSPLANTATION FROM LIVE DONORSThe Lancet, 1989
- Liver Transplantation for Malignant DiseaseAnnals of Surgery, 1988